However, 2023 expects more clinical trials using CRISPR-based gene therapies and potentially more government think tanks to formulate regulations.
So far, scientists have used it to reduce the severity of genetic deafness in mice and edited bone marrow cells in mice to treat sickle-cell anemia. However, 2023 expects more clinical trials using CRISPR-based gene therapies and potentially more government think tanks to formulate regulations. However, it is to be noted that using CRISPR on human cells or embryos in Canada is still a criminal offence.